BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.89B |
| 2 |
Amazon
AMZN
|
+$3.22B |
| 3 |
Microsoft
MSFT
|
+$2.88B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.68B |
| 5 |
Visa
V
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$1.44B |
| 2 |
AZPN
Aspen Technology Inc
AZPN
|
+$914M |
| 3 |
ALTR
Altair Engineering Inc
ALTR
|
+$816M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$689M |
| 5 |
Williams-Sonoma
WSM
|
+$683M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.85% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 9.94% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
3626
DELISTED
Inozyme Pharma
INZY
| $3.41M | ﹤0.01% |
3,745,117
-67,422
| -2% | -$93.5K |
|
|
BLUE
3627
DELISTED
bluebird bio
BLUE
| $3.41M | ﹤0.01% |
697,973
-10,696
| -2% | -$64.3K |
|
|
KG
3628
Kestrel Group
KG
$71.3M
| $3.39M | ﹤0.01% |
297,439
-4,255
| -1% | -$80.2K |
|
3629
Jasper Therapeutics
JSPR
$22.9M
| $3.39M | ﹤0.01% |
787,605
-20,481
| -3% | -$136K |
|
3630
Gossamer Bio
GOSS
$66.5M
| $3.38M | ﹤0.01% |
3,072,773
+43,564
| +1% | +$50.4K |
|
|
BHR.PRB
3631
Braemar Hotels & Resorts 5.50% Series B Preferred Stock
BHR.PRB
$53.3M
| $3.37M | ﹤0.01% |
259,291
-30,450
| -11% | -$430K |
|
3632
Corvus Pharmaceuticals
CRVS
$1.1B
| $3.36M | ﹤0.01% |
1,057,018
-15,923
| -1% | -$75K |
|
3633
Greenwich LifeSciences
GLSI
$191M
| $3.36M | ﹤0.01% |
352,191
-5,653
| -2% | -$68.6K |
|
3634
iShares US Financial Services ETF
IYG
$2.13B
| $3.34M | ﹤0.01% |
42,570
-29,744
| -41% | -$2.4M |
|
3635
Children's Place
PLCE
$53.6M
| $3.34M | ﹤0.01% |
382,548
+161,564
| +73% | +$1.5M |
|
3636
Meridian
MRBK
$236M
| $3.34M | ﹤0.01% |
231,779
+11,073
| +5% | +$169K |
|
3637
Kenon Holdings
KEN
$3.61B
| $3.31M | ﹤0.01% |
103,436
+5,369
| +5% | +$172K |
|
3638
Kimbell Royalty Partners
KRP
$1.47B
| $3.29M | ﹤0.01% |
234,758
+27,696
| +13% | +$418K |
|
3639
Alamos Gold
AGI
$12.4B
| $3.27M | ﹤0.01% |
122,420
-2,194
| -2% | -$49.5K |
|
3640
Invivyd
IVVD
$180M
| $3.24M | ﹤0.01% |
5,349,314
+605,758
| +13% | +$543K |
|
3641
Kyverna Therapeutics
KYTX
$450M
| $3.24M | ﹤0.01% |
1,676,268
+3,775
| +0.2% | +$11.2K |
|
3642
Vuzix
VUZI
$190M
| $3.21M | ﹤0.01% |
1,574,112
+179,695
| +13% | +$589K |
|
3643
Frontline
FRO
$8.75B
| $3.21M | ﹤0.01% |
216,217
-69,047
| -24% | -$1.14M |
|
3644
Pyxis Oncology
PYXS
$165M
| $3.21M | ﹤0.01% |
3,271,974
-72,167
| -2% | -$96.3K |
|
3645
American Outdoor Brands
AOUT
$162M
| $3.2M | ﹤0.01% |
263,305
-11,592
| -4% | -$178K |
|
3646
Alto Ingredients
ALTO
$360M
| $3.2M | ﹤0.01% |
2,804,527
+675,702
| +32% | +$1.05M |
|
3647
Vanguard Dividend Appreciation ETF
VIG
$111B
| $3.19M | ﹤0.01% |
16,466
+2,012
| +14% | +$400K |
|
|
NOVA
3648
DELISTED
Sunnova Energy
NOVA
| $3.19M | ﹤0.01% |
8,586,419
-493,675
| -5% | -$950K |
|
3649
Carlyle Secured Lending
CGBD
$698M
| $3.19M | ﹤0.01% |
197,325
-5,875
| -3% | -$104K |
|
3650
iShares Russell Mid-Cap Growth ETF
IWP
$19.7B
| $3.19M | ﹤0.01% |
27,168
-86,999
| -76% | -$11.2M |
|
Similar funds
BlackRock's Q1 2025 Portfolio in Review
As of Q1 2025, BlackRock held 5,602 positions worth $4.76T, down 3.7% from $4.94T the previous quarter. Its ten largest holdings account for 25% of the portfolio.
BlackRock's Q1 2025 filing shows 211 new, 1,923 increased, 2,656 reduced and 168 closed positions. Its largest new stake was Sandisk: 14,395,767 shares worth $685M. The largest sale was iShares Core MSCI Total International Stock ETF, an estimated $1.44B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q1 2025 buy was Sandisk: 14,395,767 shares worth $685M.
- BlackRock added most to Apple in Q1 2025, an estimated $3.89B increase.
- BlackRock's biggest Q1 2025 reduction was iShares Core MSCI Total International Stock ETF, cutting an estimated $1.44B.
- BlackRock fully exited Aspen Technology Inc in Q1 2025, selling an estimated $914M.
- BlackRock's ten largest holdings make up 25% of its $4.76T portfolio in Q1 2025.
- BlackRock opened 211 new positions and closed 168 in Q1 2025.
- BlackRock's portfolio value fell 3.7% quarter-over-quarter to $4.76T.
Based on BlackRock's 13F filing for Q1 2025, filed 2 May 2025.